PBF-1650
/ Palobiofarma, Xoma
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
June 30, 2020
Study to Assess the Safety and Tolerability of PBF-1650 in Healthy Volunteers.
(clinicaltrials.gov)
- P1; N=32; Completed; Sponsor: Palobiofarma SL; Recruiting ➔ Completed
Clinical • Trial completion • Dermatology • Dermatopathology • Immunology • Psoriasis
1 to 1
Of
1
Go to page
1